Skip to Content

WATSON 425 (Aspirin, Butalbital, Caffeine and Codeine Phosphate 325 mg / 50 mg / 40 mg / 30 mg)

Pill with imprint WATSON 425 is Blue & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital, Caffeine and Codeine Phosphate 325 mg / 50 mg / 40 mg / 30 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 425

Aspirin, Butalbital, Caffeine and Codeine Phosphate

Imprint:
WATSON 425
Strength:
325 mg / 50 mg / 40 mg / 30 mg
Color:
Blue & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide